In 2025, the Chile market accounted for USD 1.92 billion.
As per our research findings, the Chile Infusion Services Market to exceed USD 5.10 billion by 2033, with an estimated CAGR of 13.0% during the forecast period.
Strong public-private healthcare integration sustains biologic infusion access, with Santiago-based tertiary centers leading systemic therapy administration.
Chilean Ministry of Health oncology data confirm ongoing treatment expansion, supporting stable infusion capacity utilization.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]